Use of beta-adrenolytics in treatment of hyperthyroidism in pregnant women
Pisarek-Miedzińska, D.; Czech, W.
Polski Tygodnik Lekarski 46(17-18): 323-324
1991
ISSN/ISBN: 0032-3756 PMID: 1669064 Document Number: 376218
Use of propranolol in the treatment of hyperthyreosis in pregnant women is discussed. It was noted, that propranolol given for 24-28 days in low doses, starting from the 34th-35th week of pregnancy, and in higher doses during 5 or 2 days preceding labour diminishes clinical symptoms of hyperthyreosis. It influences thyreotropic hormone levels. No side effects were seen in neonates of mothers treated with propranolol; thyreotrophic hormone levels were within normal values.